US Broker Ratings

Vaxcyte, Inc. (PCVX) Investor Outlook: Analyzing a 91% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX), a burgeoning entity in the biotechnology sector, has captured the attention of investors with its promising portfolio of vaccine candidates and an impressive potential upside of..

Biogen Inc. (BIIB) Investor Outlook: Exploring a 16% Potential Upside with Strong Buy Ratings

Biogen Inc. (BIIB), a leading player in the healthcare sector, particularly in the drug manufacturing industry, presents an intriguing opportunity for investors. With a market capitalization of $27.62 billion, the..

The Ensign Group, Inc. (ENSG) Investor Outlook: A 20% Upside with Strong Buy Ratings

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.73 billion, this..

RadNet, Inc. (RDNT) Stock Analysis: A 58% Potential Upside Driven by Diagnostic Innovation

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, offers a compelling opportunity for investors looking to capitalize on the growing demand for diagnostic imaging services. The company,..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 28.5% Potential Upside for Healthcare Investors

Baxter International Inc. (NYSE: BAX) stands at an intriguing juncture for investors seeking opportunities in the healthcare sector. With its current market capitalization at $8.88 billion, Baxter is a prominent..

Labcorp Holdings Inc. (LH) Stock Analysis: A 21% Potential Upside That Investors Can’t Ignore

For those with a keen eye on the healthcare sector, Labcorp Holdings Inc. (NYSE: LH) presents an intriguing investment opportunity. With a market capitalization of $21.06 billion, this major player..

BioNTech SE (BNTX) Stock Analysis: Unveiling a 33.91% Potential Upside in the Biotech Sector

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured the spotlight of global investors following its pivotal role in developing the mRNA vaccine for COVID-19. Headquartered..

Align Technology, Inc. (ALGN) Investor Outlook: Exploring a 16.86% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, is capturing investor attention with its innovative orthodontic and digital scanning solutions. With a market capitalization of $12.81..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a 92% Upside Potential in the Biotech Sector

Telix Pharmaceuticals Limited (ASX: TLX), a frontrunner in the biotechnology sector, presents an intriguing investment opportunity with a compelling 92% potential upside based on analyst target prices. With a market..

United Therapeutics Corporation (UTHR) Stock Analysis: Navigating Growth and Innovation in Healthcare

United Therapeutics Corporation (NASDAQ: UTHR) has been making waves in the healthcare sector with its robust pipeline and innovative treatments targeting chronic and life-threatening diseases. With a market cap of..

STERIS plc (STE) Stock Analysis: Exploring a Promising 30% Upside Potential

Investors eyeing the healthcare sector might find STERIS plc (STE) an intriguing prospect, especially given its potential upside of over 30% based on analyst target prices. With a market cap..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 31% Potential Upside

As the healthcare landscape continues to evolve, GE HealthCare Technologies Inc. (NYSE: GEHC) stands out as a key player in the medical devices industry, boasting a robust market capitalization of..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Promising 91% Upside in the Biotech Sector

Investors with an eye on the biotechnology sector might find Summit Therapeutics Inc. (NASDAQ: SMMT) an intriguing opportunity, given the significant potential upside of 91.42% as indicated by current analyst..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Robust Revenue Growth Offers 31.75% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) has been generating significant interest in the biotechnology sector, attracting investors with its innovative approach to B-cell mediated diseases. With a market capitalization of $5.4..

Exact Sciences Corporation (EXAS) Stock Analysis: Evaluating Growth in Cancer Diagnostics with a $20 Billion Market Cap

Exact Sciences Corporation (NASDAQ: EXAS) continues to capture investor attention with its robust standing in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Madison, Wisconsin, this..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A 24.79% Upside Potential Beckons Investors

Investors eyeing Takeda Pharmaceutical Company Limited (NYSE: TAK) will find a compelling narrative of potential growth amidst a robust healthcare sector. With a significant market capitalization of $52.51 billion, Takeda..

Insulet Corporation (PODD) Stock Analysis: A Healthcare Powerhouse with 86% Potential Upside

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector as a leading innovator in the medical devices industry, with a specific focus on insulin delivery systems. As the demand..

Legend Biotech Corporation (LEGN): Investor Outlook with a 142.62% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its promising biotechnology pipeline, particularly in the rapidly evolving field of oncology. With a market capitalization of $4.36..

Elevance Health, Inc. (ELV): Investor Outlook on a Healthcare Giant with a Solid Dividend Yield

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare sector, presents an intriguing opportunity for investors looking to gain exposure to the robust U.S. healthcare market. With a..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 31.36% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the healthcare sector, is capturing investor attention, not least due to its considerable potential upside of 31.36%. As a key entity in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds